Merck & Co (MRK)
$81.39 1.30 (1.57%)
17:28 EDT MRK Stock Quote Delayed 15 Minutes
Previous Close $81.39
Market Cap 218.96B
PE Ratio 140.33
Volume (Avg. Vol.) 11.50M
Day's Range 81.15 - 82.82
52-Week Range 62.38 - 87.07
Dividend & Yield 1.92 (2.36%)
MRK Stock Predictions, Articles, and Merck & Co News
- From InvestorPlace
- From the Web
Longstanding cycles in CVS Health and Merck are at risk of changing and offering profits to spread traders buying CVS stock and shorting MRK.
Options trading was buzzing in Bed Bath & Beyond, CVS, and Merck on Thursday. Here are the metrics that matter moving forward.
The stock charts of HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals are poised to end the trading week in a pivotal situation.
As has been noted in this space, market participants are pricing in the following Fed facts: no interest rate cut this month and no cuts totaling 50 basis points this year. Hope burns eternal for a rate reduction of 25 basis points, but Powell's two-day testimony and the June meeting minutes could indicate otherwise.
Despite all the fear around prescription drug prices, there are some excellent healthcare stocks to buy for interested investors.
Play a friendly and widening price spread in biotech stocks with a well-place purchase in Merck and an equally smart short in AbbVie.
Investors are punishing Bristol-Myers on the markets more than they should. BMY stock's acquisition of Celgene isn't the only reason.
Smaller-capitalization biotechs can be riskier investments, but EXEL stock has more than just promise off and on the price chart and is readying to be purchased.
Pfizer, Walgreens and Merck are just three of the Dow Jones stocks that have kept the index from doing as well as other market indices have this year.
These ten stocks aren't exactly household names, but they each deserve a spot in a list of small-cap stocks to buy now for traders that can deal with the risk for the potential of high reward.
With the Mueller investigation finding no evidence of a Trump-Russia collusion, Dow Jones stocks have one less variable to worry about.
Options trading was buzzing in Aurora Cannabis, Roku and Merck on Wednesday. Here are the metrics that matter moving forward.
These Dow Jones stocks are looking for more upside this year and are worth a closer look from savvy investors.
Despite positive news in the U.S.-China trade war boosting speculative trading, you can’t go wrong with steady blue-chip stocks.
Merck news about the pharmaceutical company's performance during the fourth quarter of the year has MRK stock up on Friday.
From Talk Markets
From Talk Markets
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!